tiprankstipranks
Chimeric Therapeutics Ltd. (AU:CHM)
ASX:CHM
Australian Market
Want to see AU:CHM full AI Analyst Report?

Chimeric Therapeutics Ltd. (CHM) Financial Statements

13 Followers

Chimeric Therapeutics Ltd. Financial Overview

Chimeric Therapeutics Ltd.'s market cap is currently AU$767.25K. The company's EPS TTM is AU$-0.95; its P/E ratio is >-0.01; Chimeric Therapeutics Ltd. is scheduled to report earnings on August 28, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 3.97MAU$ 7.46MAU$ 4.51MAU$ 2.62M
Gross ProfitAU$ 0.00AU$ 3.12MAU$ 7.45MAU$ 3.54MAU$ 1.67M
Operating IncomeAU$ -8.36MAU$ -15.11MAU$ -12.31MAU$ -29.49MAU$ -14.57M
EBITDAAU$ -8.36MAU$ -9.08MAU$ -11.30MAU$ -28.59MAU$ -13.62M
Net IncomeAU$ -18.81MAU$ -10.43MAU$ -12.53MAU$ -25.92MAU$ -15.90M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 800.14KAU$ 5.76MAU$ 3.05MAU$ 5.37MAU$ 18.38M
Total AssetsAU$ 1.28MAU$ 21.57MAU$ 15.27MAU$ 22.38MAU$ 34.88M
Total DebtAU$ 679.85KAU$ 0.00AU$ 3.59MAU$ 0.00AU$ 0.00
Net DebtAU$ -120.30KAU$ -5.76MAU$ -3.05MAU$ -5.37MAU$ -18.38M
Total LiabilitiesAU$ 9.00MAU$ 19.60MAU$ 12.80MAU$ 16.71MAU$ 9.17M
Stockholders' EquityAU$ -7.72MAU$ 1.97MAU$ 2.47MAU$ 5.66MAU$ 25.71M
Cash Flow
Free Cash FlowAU$ 0.00AU$ -7.28MAU$ 10.11KAU$ -16.43MAU$ -13.69M
Operating Cash FlowAU$ -10.78MAU$ -7.28MAU$ -7.54MAU$ -16.32MAU$ -13.15M
Investing Cash FlowAU$ -249.34KAU$ 0.00AU$ 0.00AU$ -112.19KAU$ -577.86K
Financing Cash FlowAU$ 6.08MAU$ 10.05MAU$ 8.26MAU$ 253.38KAU$ 9.50M
Currency in AUD

Chimeric Therapeutics Ltd. Earnings and Revenue History

Chimeric Therapeutics Ltd. Debt to Assets

Chimeric Therapeutics Ltd. Cash Flow

Chimeric Therapeutics Ltd. Forecast EPS vs Actual EPS